Compare GOCO & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOCO | BTMD |
|---|---|---|
| Founded | 2001 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.3M | 80.4M |
| IPO Year | 2020 | N/A |
| Metric | GOCO | BTMD |
|---|---|---|
| Price | $2.50 | $2.62 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $5.00 | ★ $6.00 |
| AVG Volume (30 Days) | 40.3K | ★ 123.2K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | N/A | ★ 0.78 |
| Revenue | ★ $738,338,000.00 | $195,645,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.80 |
| P/E Ratio | ★ N/A | $3.43 |
| Revenue Growth | ★ 7.56 | 1.34 |
| 52 Week Low | $2.17 | $2.32 |
| 52 Week High | $21.00 | $6.70 |
| Indicator | GOCO | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 34.15 | 48.86 |
| Support Level | $2.80 | $2.55 |
| Resistance Level | $3.41 | $2.90 |
| Average True Range (ATR) | 0.21 | 0.14 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 1.08 | 36.59 |
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.